Creatine for Women: Cognition & Bone Health Data

Creatine monohydrate has an image problem. For thirty years it's been marketed to men in weight rooms, which is a shame — because some of the most interesting recent data is in women, and it has almost nothing to do with a bench press.

We're going to walk through what the cognition, mood, and bone data actually show, where the trade-offs are, and what a reasonable protocol looks like if you decide it fits.

What creatine actually does — in plain English

Creatine is a compound your body already makes (about 1 g/day from the liver and kidneys) and that you get from meat and fish (roughly another 1 g/day on a mixed diet). It's stored mostly in muscle, where it helps regenerate ATP — the molecule cells use for short, high-demand energy bursts.

The brain also uses creatine. So do bone-forming cells. That's the anatomical reason the research has broadened.

Women tend to store 70–80% as much creatine as men at baseline and consume less through diet, which is part of why supplementation appears to produce larger relative effects in women than in men in some domains (Smith-Ryan et al., Nutrients, 2021).

The cognition data — what actually changes

This is where the last five years have shifted the conversation.

A 2023 systematic review in Nutrition Reviews looked at 16 randomized trials of creatine and cognitive performance. The clearest signals were in short-term memory and reasoning under conditions of stress — specifically sleep deprivation, mental fatigue, and aging (Prokopidis et al., 2023).

A 2024 randomized trial published in Scientific Reports found that a single 0.35 g/kg dose of creatine (roughly 20–25 g for most adults) partially rescued cognitive performance and brain high-energy phosphate levels during 21 hours of sleep deprivation (Gordji-Nejad et al., 2024).

The mood data is smaller but interesting. A 2022 pilot study in women with major depressive disorder found that adding 5 g/day of creatine to an SSRI improved response rates versus SSRI alone (Lyoo et al., 2012), and ongoing trials are looking at creatine as an adjunct in treatment-resistant depression.

None of this makes creatine a nootropic in the marketing sense. It's not going to make a well-rested person smarter. But if you're sleep-deprived, perimenopausal, or dealing with the cognitive fog that often accompanies hormonal shifts, the mechanism is plausible and the data is real.

The bone data — worth paying attention to

This is the one most women haven't heard about.

A 2015 double-blind RCT in postmenopausal women combined 12 months of resistance training with either 0.1 g/kg/day creatine or placebo. The creatine group preserved femoral neck bone mineral density and improved a key bone geometry marker (section modulus, a proxy for bone strength) compared to placebo (Chilibeck et al., Medicine & Science in Sports & Exercise, 2015).

A longer 2023 follow-up analysis reinforced the finding: creatine plus resistance training slowed hip bone loss in postmenopausal women more than resistance training alone.

Important caveat: creatine alone, without loading the skeleton through resistance training, does not appear to build bone. The two work together. Creatine seems to support the recovery and remodeling process that resistance training triggers — it's not a substitute for the training itself.

{callout: The takeaway} For women over 40, creatine's most compelling case isn't muscle — it's the combination of cognitive support during hormonal transitions and bone-density preservation when paired with resistance training.

What about muscle? — yes, that too

We'd be dishonest to skip it. Creatine remains the most-studied ergogenic aid in sports nutrition, with consistent effects on strength (roughly 5–15% improvement in 1-rep max metrics across meta-analyses) and lean mass (1–2 kg over 4–12 weeks in most trials) when combined with resistance training (Kreider et al., JISSN, 2017).

In women specifically, the strength gains are consistent; lean-mass gains tend to be smaller in absolute terms than in men, which is a function of hormonal biology, not creatine failing.

Dosing, timing, and the loading question

The published research clusters around two protocols:

• Standard daily dose: 3–5 g/day, taken any time, with or without food. Saturates muscle stores in about 3–4 weeks.
• Loading protocol: 20 g/day (split into 4 doses) for 5–7 days, then 3–5 g/day maintenance. Saturates in about a week but is more likely to cause GI upset.

Most people don't need to load. The daily maintenance dose gets you to the same place, just a few weeks later, with fewer side effects.

Timing matters less than consistency. Taking it with a meal that contains carbohydrate or protein modestly improves uptake, but the difference is small.

Common concerns — let's be honest about them

Water weight. Yes, creatine pulls water into muscle cells. Most people gain 1–2 lb of intracellular water in the first few weeks. This is not fat and it is not bloating in the subcutaneous sense — but it is real, and if you're weighing yourself daily it will show up.

Kidneys. In people with normal kidney function, creatine at standard doses has not been shown to impair renal function across dozens of trials, some running multiple years. If you have pre-existing kidney disease, that's a conversation with your clinician.

Hair loss. This concern traces back to a single 2009 study in male rugby players that showed a rise in DHT after creatine loading. The finding has not been replicated, and no study has directly measured hair loss as an outcome. It's worth knowing about, not worth panicking about.

Which form? Creatine monohydrate. That's it. "HCL," "buffered," "ethyl ester," and the rest are marketing. Monohydrate is the form that's been studied in essentially every trial cited above, it's the cheapest, and it works.

Labs and context worth considering

Creatine doesn't require monitoring in healthy adults, but a few markers are useful context if you're building a broader supplement or performance protocol. The labs worth having before a serious protocol include a basic metabolic panel (for kidney function baseline), vitamin D, ferritin, and — for women in the perimenopausal window — a hormone panel that captures estradiol, FSH, and thyroid.

Creatine is not a hormone, not a stimulant, and not a shortcut. It's a small nudge to a biochemical pathway your body already runs — and in women, that nudge appears to matter more than we used to think.

If you're considering creatine as part of a broader plan around perimenopause, cognitive support, or bone health, it's the kind of decision that benefits from context: your training, your other supplements, and — if you choose to run them — your labs.

Bottom line

Creatine monohydrate is cheap, well-studied, and increasingly relevant to women for reasons that have nothing to do with the gym. The cognition data is strongest under stress and sleep deprivation. The bone data is strongest when paired with resistance training. The muscle data is, and always has been, solid.

3–5 g/day of plain monohydrate, taken consistently, is the protocol the evidence supports. Everything else is noise.

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.